ABT · News · 20260811N
Revenue Performance and Mix
ABBOTT LABORATORIES · 2026-08-11 · Importance 37 · Surprise 6 · In source text
Abbott reported $12.59 billion in quarterly revenue and adjusted earnings of $1.31 per share, exceeding analyst expectations. Medical Devices is experiencing strong growth, with continuous glucose monitoring sales exceeding $2 billion. Cancer diagnostics and Medical Devices drove the company’s quarterly estimate beat, while Established Pharmaceuticals and Nutrition also showed positive trends.
Key facts
- Abbott Laboratories reported $12.59 billion in revenue for the quarter and adjusted earnings of $1.31 per share. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | unclear | realized | — | Abbott Laboratories reported $12.59 billion in revenue for the quarter and adjusted earnings of $1.31 per share. |